Dara Biosciences (DARA) 0.88 $DARA DARA BioSciences wins

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dara Biosciences (DARA) 0.88 $DARA

DARA BioSciences wins stockholder's approval of merger with and into Midatech
M2 - Thu Dec 03, 5:27AM CST
DARA BioSciences (NasdaqCMARA) reported on Wednesday the receipt of stockholders' approval for the adoption of the merger agreement by and among DARA, Midatech Pharma PLC (Midatech) and certain other parties thereto.
DARA: 0.88 (-0.06)

DARA BioSciences Announces Stockholder Approval of Merger With Midatech
Marketwired - Wed Dec 02, 3:30PM CST
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that its stockholders have approved the adoption of the previously announced merger agreement by and among DARA, Midatech Pharma PLC ("Midatech" and certain other parties thereto.
DARA: 0.88 (-0.06)

DARA BioSciences posts higher loss of USD2.7m for Q3 2015
M2 - Tue Nov 03, 4:21AM CST
Pharmaceutical company DARA BioSciences (NasdaqCMARA) disclosed on Monday that it recorded a loss attributable to controlling interest of approximately USD2.7m (USD0.14 per share) for the third quarter ended 30 September 2015.
DARA: 0.88 (-0.06)

DARA BioSciences Announces Third Quarter 2015 Results
Marketwired - Mon Nov 02, 3:30PM CST
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced its third quarter 2015 results.
DARA: 0.88 (-0.06)

DARA BioSciences to Present at the 2015 Aegis Growth Conference on October 8, 2015
Marketwired - Tue Oct 06, 7:02AM CDT
DARA BioSciences, Inc. (NASDAQ: DARA) today announced that it will be featured as a presenting company at the 2015 Aegis Growth Conference, sponsored by Aegis Capital Corp. The Aegis Growth Conference, which will feature growth companies in Healthcare, Technology, Telecom and Aerospace-Defense sectors, will be held October 7-9, 2015 at The Encore at Wynn Hotel in Las Vegas, NV. DARA BioSciences is an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment.
DARA: 0.88 (-0.06)

DARA BioSciences unveils Oravig (miconazole) in the oncology and primary care markets in the US for treatment of adults with oral thrush
M2 - Tue Oct 06, 4:36AM CDT
Specialist pharmaceutical company DARA BioSciences (NasdaqCMARA) reported on Monday the availability of Oravig, the first and only orally-dissolving muco-adhesive buccal tablet approved to treat adults with oral thrush, into the oncology and primary care markets in the US.
DARA: 0.88 (-0.06)

DARA BioSciences Announces U.S. Launch of Oravig(R) (miconazole), the First and Only Orally-Dissolving Buccal Tablet Available for Treatment of Adults With Oral Thrush
Marketwired - Mon Oct 05, 7:01AM CDT
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments, announced today the U.S. launch of Oravig -- the first and only orally-dissolving muco-adhesive buccal tablet approved to treat adults with oral thrush -- into the Oncology and Primary Care markets. Beginning this week, DARA and its marketing partner Mission Pharmacal Company, a privately held pharmaceutical company based in San Antonio, TX, will simultaneously begin promotion of Oravig with two separate sales forces focusing on the highest prescribing physicians of oral thrush therapy; DARA will promote Oravig exclusively in Oncology with its 20 person nationwide sales force and Mission will utilize its 40 person-strong sales team to promote the product exclusively to the Primary Care market. DARA was granted exclusive U.S. rights to Oravig in March 2015, under a Commercialization Agreement with Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs.
DARA: 0.88 (-0.06)

DARA BioSciences to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015
Marketwired - Wed Sep 23, 3:30PM CDT
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that it will be featured as a presenting company at the Ladenburg Thalmann 2015 Healthcare conference. The conference is being held September 29, 2015, at the Sofitel Hotel in New York City.
DARA: 0.88 (-0.06)

DARA BioSciences to Present at the 17th Annual Rodman and Renshaw Global Investment Conference on September 9, 2015
Marketwired - Wed Sep 02, 3:30PM CDT
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that it will be featured as a presenting company at the Rodman and Renshaw Global Investment Conference. The conference is being held September 8-10, 2015, at the Saint Regis Hotel in New York City.
DARA: 0.88 (-0.06)

DARA BioSciences Announces Second Quarter 2015 Results
Marketwired - Wed Aug 12, 3:15PM CDT
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced its second quarter 2015 results.
DARA: 0.88 (-0.06)

DARA BioSciences Announces Date and Time for Announcement of Second Quarter 2015 Results
Marketwired - Mon Aug 10, 7:00AM CDT
DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that it will release financial results for the second quarter ended June 30, 2015, after the close of the market on Wednesday, August 12, 2015.
DARA: 0.88 (-0.06)

Robbins Arroyo LLP: Acquisition of DARA BioSciences, Inc. (DARA) by Midatech Pharma Plc (MTPH) May Not Be in Shareholders' Best Interests
PR Newswire - Thu Jun 25, 2:49PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of DARA BioSciences Inc. (NASDAQ: DARA) by Midatech Pharma Plc (London: MTPH). On June 4, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which Midatech will acquire DARA. Under the terms of the agreement, DARA shareholders will receive 0.272 shares of Midatech for each share of DARA they own, the value of which is equivalent to $1.20 per share of DARA common stock.
DARA: 0.88 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 29

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 88

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 185

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 183

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 163

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 91

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Veterans Find a Haven in Home Helpers® Franchise

Updated Category News Views 108

Veterans Thriving at Home Helpers® Tossing out a warm welcome to fresh horizons post-military, Home Helpers® Home Care is serving up more than just compassionate care—it’s become a bonafide haven for veterans diving into the world of franchising. This isn’t just an indie pat on the back; according to the latest scoop from Franchise Business Review, Home Helpers®...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 78

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 164

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading

Top 5 Most Recently Viewed Articles

H&E Equipment Services Reveals Q3 2024 Performance Insights

Updated Category News Views 338

H&E Equipment Services Reports Q3 2024 Financial Results H&E Equipment Services, Inc. (NASDAQ: HEES), commonly known as H&E Rentals, recently issued its financial results for the third quarter of 2024. The Company has made significant strides in expanding its branch network, adding eight new locations during the quarter, which brings its total to 157 branches across...

Continue Reading
Automotive V2X Market Trends: A Roadmap to 2031

Updated Category News Views 148

Automotive V2X Market Growth Insights The automotive V2X (Vehicle-to-Everything) market is set for a remarkable transformation, anticipated to expand with a compound annual growth rate of 25.1% from 2024 to 2031. The market is projected to reach a size of US$2.3 billion by 2031. Insights from recent research indicate a shift in dynamics within this evolving market,...

Continue Reading
Toll Brothers Celebrates New Luxury Amenities in Forestville Village

Updated Category News Views 250

Toll Brothers Introduces Exceptional Amenities Toll Brothers, Inc. (NYSE:TOL), a well-respected name in luxury homebuilding, recently celebrated the opening of a fantastic amenity center at Forestville Village. This vibrant community in Knightdale features beautifully designed single-family homes and townhomes, now enhanced with access to resort-style amenities. A...

Continue Reading
Acadia Pharmaceuticals Celebrates Strong Q3 2024 Financial Growth

Updated Category News Views 58

Acadia Pharmaceuticals Reports Financial Results for Q3 2024 Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) has shared encouraging financial results for the third quarter of 2024. The company has showcased a remarkable performance that reflects its strong commercial presence and growth within the pharmaceutical industry. This report provides insights into the company's...

Continue Reading
Crowley Enhances Logistics for Wreaths Across America Initiative

Updated Category News Views 208

Crowley Enhances Logistics for Wreaths Across America Initiative Crowley is taking significant steps to expand its logistical support for the Wreaths Across America program, reflecting its strong commitment to honoring U.S. military personnel. The company is facilitating this through financial sponsorship along with in-kind transportation and logistics services. Expanded...

Continue Reading